No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Subdued Growth No Barrier To Ascendis Pharma A/S' (NASDAQ:ASND) Price
$1000 Invested In Ascendis Pharma 10 Years Ago Would Be Worth This Much Today
European Equities Traded in the US as American Depositary Receipts Trend Lower Thursday
Wells Fargo Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Cuts Target Price to $260
The Small-Cap Stock Boom Is Overdue. This Fund Is Ready.
Ascendis Pharma, Pendopharm Sign Distribution Agreement for TransCon Parathyroid Hormone in Canada